BlockBeats News, July 30th, according to RockFlow market data, US Stock Market Altcoin MicroStrategy Stocks experienced a widespread decline, including:
ETH MicroStrategy Stocks:
Bitmine Immersion (BMNR) dropped by 7.6%, with the stock price currently at $32.38, trading volume of $1.092 billion;
SharpLink Gaming (SBET) plunged over 10%, with the stock price currently at $18.74, trading volume of $547 million;
Bit Digital (BTBT) fell by 6.5%, with the stock price currently at $2.80, trading volume of $64.70 million;
BTCS Inc (BTCS) declined by 4.52%, with the stock price currently at $4.92, trading volume of $14.80 million.
BNB MicroStrategy Stocks:
CEA Industries (VAPE) experienced a significant drop of over 30%, with the stock price currently at $40.64, trading volume of $50 million;
Windtree Therapeutics (WINT) dropped by 16.4%, with the stock price currently at $0.77, trading volume of $4.20 million.
SOL MicroStrategy Stocks:
DeFi Development Corp (DFDV) fell by 9.75%, with the stock price currently at $16.15, trading volume of $30.80 million.
LTC MicroStrategy Stocks:
MEI Pharma (MEIP) dropped by 11.76%, with the stock price currently at $5.25, trading volume of $3.53 million.
TRX MicroStrategy Stocks:
TRON. Inc (TRON) plunged by 15.94%, with the stock price currently at $9.12, trading volume of $36.20 million.
HYPE MicroStrategy Stocks:
Hyperion DeFi (HYPD) fell by 12.11%, with the stock price currently at $8.35, trading volume of $3.16 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.